Why ARRIVE should not thrive in Australia

Published last week and surrounded by a flurry of commentary and social media was the ARRIVE trial.1 This trial was based on the hypothesis that elective induction of labour at 39weeks would reduce perinatal mortality and morbidity. Across 41 hospitals in the United States, more than 6000 low-risk nulliparous women who were at 34weeks 0days to 38weeks 6days of gestation were randomised to either to induction of labour at 39weeks 0days to 39weeks 4days or to expectant management, which meant waiting beyond 40weeks and 5days to be induced but no later than 42weeks and 2days.

Source: Women and Birth - August 30, 2018 Category: Midwifery Authors: Miranda Davies-Tuck, Euan M. Wallace, Caroline S.E. Homer Source Type: research